Mexiletine is a medication used to treat irregular heartbeats, and it has been on the market for over 35 years. It is generally considered to be a safe and effective drug, but as with any medication, there can be unexpected side effects. In this article, we will explore the potential unforeseen side effects of Mexiletine and what doctors should look out for when prescribing it.
Mexiletine is a type of antiarrhythmic drug, which means it is used to treat irregular heartbeats, or arrhythmias. It works by blocking the sodium channels in the heart, which helps to regulate the electrical activity in the heart and restore a normal rhythm. It is commonly used to treat ventricular arrhythmias, which are arrhythmias that originate in the lower chambers of the heart.
Like any medication, Mexiletine can have potential side effects. The most common side effects are nausea, vomiting, dizziness, and fatigue. It can also cause an abnormal heart rate, which can be dangerous. Other potential side effects include headaches, constipation, blurred vision, and dry mouth.
In addition to the more common side effects, there have been some reports of more serious and unexpected side effects from Mexiletine. These side effects include allergic reactions, liver and kidney damage, and even sudden death.
There have been some reports of allergic reactions to Mexiletine, which can range from mild to severe. Symptoms of an allergic reaction can include hives, rash, itching, swelling, difficulty breathing, and dizziness. If you experience any of these symptoms while taking Mexiletine, contact your doctor immediately.
There have also been reports of liver and kidney damage due to Mexiletine. This is especially concerning, as the liver and kidneys are responsible for filtering out toxins from the body. If these organs are damaged, it can lead to a buildup of toxins in the body, which can be dangerous.
There have also been reports of sudden death due to Mexiletine. This is extremely rare, but it is still important to be aware of the possibility. If you experience any signs of an arrhythmia, such as chest pain or shortness of breath, contact your doctor immediately.
When prescribing Mexiletine, it is important for doctors to be aware of the potential side effects, both common and unexpected. They should also monitor their patients closely for any signs of an allergic reaction, liver or kidney damage, or an arrhythmia.
Mexiletine is a medication used to treat irregular heartbeats, and it is generally considered to be a safe and effective drug. However, there have been some reports of more serious and unexpected side effects, such as allergic reactions, liver and kidney damage, and even sudden death. It is important for doctors to be aware of these potential side effects when prescribing Mexiletine, and to monitor their patients closely for any signs of these side effects.
1.
A study outlines the need for policies that enhance cancer patients' autonomy and information.
2.
New CAR T-Cell Therapy Approved for Leukemia
3.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
4.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
5.
Alone for 500 Days, but Never Lonely: The Introvert's Dream.
1.
Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care
2.
Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target
5.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
2.
Thromboprophylaxis In Medical Settings
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation